COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
FRA:CBHD - Deutsche Boerse Ag - DK0060448595 - Common Stock - Currency: EUR
Overall CBHD gets a fundamental rating of 5 out of 10. We evaluated CBHD against 60 industry peers in the Health Care Equipment & Supplies industry. While CBHD has a great profitability rating, there are quite some concerns on its financial health. CBHD has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year CBHD was profitable.
CBHD had a positive operating cash flow in the past year.
Each year in the past 5 years CBHD has been profitable.
Each year in the past 5 years CBHD had a positive operating cash flow.
1.2 Ratios
The Return On Assets of CBHD (10.51%) is better than 87.27% of its industry peers.
Looking at the Return On Equity, with a value of 28.16%, CBHD belongs to the top of the industry, outperforming 96.36% of the companies in the same industry.
The Return On Invested Capital of CBHD (15.24%) is better than 96.36% of its industry peers.
CBHD had an Average Return On Invested Capital over the past 3 years of 16.81%. This is significantly above the industry average of 7.96%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.51% | ||
| ROE | 28.16% | ||
| ROIC | 15.24% |
ROA(3y)11%
ROA(5y)18.91%
ROE(3y)37.52%
ROE(5y)45.66%
ROIC(3y)16.81%
ROIC(5y)28.33%
1.3 Margins
CBHD has a Profit Margin of 18.69%. This is amongst the best in the industry. CBHD outperforms 89.09% of its industry peers.
In the last couple of years the Profit Margin of CBHD has declined.
CBHD's Operating Margin of 26.96% is amongst the best of the industry. CBHD outperforms 94.55% of its industry peers.
In the last couple of years the Operating Margin of CBHD has declined.
CBHD has a better Gross Margin (67.59%) than 72.73% of its industry peers.
CBHD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.96% | ||
| PM (TTM) | 18.69% | ||
| GM | 67.59% |
OM growth 3Y-6.25%
OM growth 5Y-2.74%
PM growth 3Y-9.04%
PM growth 5Y-2.84%
GM growth 3Y-0.46%
GM growth 5Y-0.05%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CBHD is creating value.
CBHD has more shares outstanding than it did 1 year ago.
CBHD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CBHD has a worse debt to assets ratio.
2.2 Solvency
CBHD has an Altman-Z score of 4.75. This indicates that CBHD is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.75, CBHD belongs to the best of the industry, outperforming 87.27% of the companies in the same industry.
The Debt to FCF ratio of CBHD is 15.98, which is on the high side as it means it would take CBHD, 15.98 years of fcf income to pay off all of its debts.
CBHD's Debt to FCF ratio of 15.98 is in line compared to the rest of the industry. CBHD outperforms 52.73% of its industry peers.
A Debt/Equity ratio of 0.96 indicates that CBHD is somewhat dependend on debt financing.
CBHD's Debt to Equity ratio of 0.96 is on the low side compared to the rest of the industry. CBHD is outperformed by 76.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.96 | ||
| Debt/FCF | 15.98 | ||
| Altman-Z | 4.75 |
ROIC/WACC2.37
WACC6.42%
2.3 Liquidity
A Current Ratio of 1.02 indicates that CBHD should not have too much problems paying its short term obligations.
The Current ratio of CBHD (1.02) is worse than 70.91% of its industry peers.
CBHD has a Quick Ratio of 1.02. This is a bad value and indicates that CBHD is not financially healthy enough and could expect problems in meeting its short term obligations.
CBHD's Quick ratio of 0.66 is on the low side compared to the rest of the industry. CBHD is outperformed by 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.02 | ||
| Quick Ratio | 0.66 |
3. Growth
3.1 Past
CBHD shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.44%.
CBHD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.72% yearly.
Looking at the last year, CBHD shows a quite strong growth in Revenue. The Revenue has grown by 9.80% in the last year.
Measured over the past years, CBHD shows a quite strong growth in Revenue. The Revenue has been growing by 8.54% on average per year.
EPS 1Y (TTM)-1.44%
EPS 3Y-0.25%
EPS 5Y2.72%
EPS Q2Q%-9.28%
Revenue 1Y (TTM)9.8%
Revenue growth 3Y11.64%
Revenue growth 5Y8.54%
Sales Q2Q%6.36%
3.2 Future
The Earnings Per Share is expected to grow by 11.69% on average over the next years. This is quite good.
Based on estimates for the next years, CBHD will show a small growth in Revenue. The Revenue will grow by 7.95% on average per year.
EPS Next Y14.15%
EPS Next 2Y14.18%
EPS Next 3Y13.85%
EPS Next 5Y11.69%
Revenue Next Year7.47%
Revenue Next 2Y7.93%
Revenue Next 3Y8.08%
Revenue Next 5Y7.95%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 33.98, CBHD can be considered very expensive at the moment.
Based on the Price/Earnings ratio, CBHD is valued a bit cheaper than the industry average as 65.45% of the companies are valued more expensively.
CBHD's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 29.35.
The Price/Forward Earnings ratio is 25.45, which means the current valuation is very expensive for CBHD.
Based on the Price/Forward Earnings ratio, CBHD is valued a bit cheaper than the industry average as 61.82% of the companies are valued more expensively.
CBHD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.98 | ||
| Fwd PE | 25.45 |
4.2 Price Multiples
CBHD's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CBHD is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 110.61 | ||
| EV/EBITDA | 20.81 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CBHD does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of CBHD may justify a higher PE ratio.
CBHD's earnings are expected to grow with 13.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.4
PEG (5Y)12.49
EPS Next 2Y14.18%
EPS Next 3Y13.85%
5. Dividend
5.1 Amount
CBHD has a Yearly Dividend Yield of 2.98%.
Compared to an average industry Dividend Yield of 2.26, CBHD pays a better dividend. On top of this CBHD pays more dividend than 92.73% of the companies listed in the same industry.
CBHD's Dividend Yield is a higher than the S&P500 average which is at 2.33.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.98% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.57%.
Dividend Growth(5Y)5.57%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
CBHD pays out 93.43% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CBHD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP93.43%
EPS Next 2Y14.18%
EPS Next 3Y13.85%
FRA:CBHD (3/7/2025, 7:00:00 PM)
99.9
-0.3 (-0.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners30.1%
Inst Owner ChangeN/A
Ins Owners35%
Ins Owner ChangeN/A
Market Cap21.00B
Analysts68.57
Price Target126.79 (26.92%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.98% |
Yearly Dividend2.81
Dividend Growth(5Y)5.57%
DP93.43%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.18%
Min EPS beat(2)-6.02%
Max EPS beat(2)-0.34%
EPS beat(4)0
Avg EPS beat(4)-4.26%
Min EPS beat(4)-6.02%
Max EPS beat(4)-0.34%
EPS beat(8)0
Avg EPS beat(8)-6.04%
EPS beat(12)1
Avg EPS beat(12)-6.08%
EPS beat(16)2
Avg EPS beat(16)-4.79%
Revenue beat(2)1
Avg Revenue beat(2)-0.01%
Min Revenue beat(2)-0.03%
Max Revenue beat(2)0.01%
Revenue beat(4)1
Avg Revenue beat(4)-1.02%
Min Revenue beat(4)-2.55%
Max Revenue beat(4)0.01%
Revenue beat(8)1
Avg Revenue beat(8)-1.4%
Revenue beat(12)4
Avg Revenue beat(12)-0.69%
Revenue beat(16)5
Avg Revenue beat(16)-0.73%
PT rev (1m)0.47%
PT rev (3m)-0.37%
EPS NQ rev (1m)0.56%
EPS NQ rev (3m)-4.69%
EPS NY rev (1m)-1.41%
EPS NY rev (3m)-3.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.91%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.98 | ||
| Fwd PE | 25.45 | ||
| P/S | 5.79 | ||
| P/FCF | 110.61 | ||
| P/OCF | 56.71 | ||
| P/B | 8.73 | ||
| P/tB | N/A | ||
| EV/EBITDA | 20.81 |
EPS(TTM)2.94
EY2.94%
EPS(NY)3.93
Fwd EY3.93%
FCF(TTM)0.9
FCFY0.9%
OCF(TTM)1.76
OCFY1.76%
SpS17.24
BVpS11.44
TBVpS-7.9
PEG (NY)2.4
PEG (5Y)12.49
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.51% | ||
| ROE | 28.16% | ||
| ROCE | 19.24% | ||
| ROIC | 15.24% | ||
| ROICexc | 15.56% | ||
| ROICexgc | 85.49% | ||
| OM | 26.96% | ||
| PM (TTM) | 18.69% | ||
| GM | 67.59% | ||
| FCFM | 5.24% |
ROA(3y)11%
ROA(5y)18.91%
ROE(3y)37.52%
ROE(5y)45.66%
ROIC(3y)16.81%
ROIC(5y)28.33%
ROICexc(3y)17.22%
ROICexc(5y)29.72%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)21.23%
ROCE(5y)39.82%
ROICexcg growth 3Y7.74%
ROICexcg growth 5Y2.01%
ROICexc growth 3Y-30.17%
ROICexc growth 5Y-21.96%
OM growth 3Y-6.25%
OM growth 5Y-2.74%
PM growth 3Y-9.04%
PM growth 5Y-2.84%
GM growth 3Y-0.46%
GM growth 5Y-0.05%
F-Score6
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.96 | ||
| Debt/FCF | 15.98 | ||
| Debt/EBITDA | 2.02 | ||
| Cap/Depr | 104.34% | ||
| Cap/Sales | 4.98% | ||
| Interest Coverage | 8.63 | ||
| Cash Conversion | 32.21% | ||
| Profit Quality | 28.03% | ||
| Current Ratio | 1.02 | ||
| Quick Ratio | 0.66 | ||
| Altman-Z | 4.75 |
F-Score6
WACC6.42%
ROIC/WACC2.37
Cap/Depr(3y)114.16%
Cap/Depr(5y)140.02%
Cap/Sales(3y)5.02%
Cap/Sales(5y)6.04%
Profit Quality(3y)58.21%
Profit Quality(5y)66.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.44%
EPS 3Y-0.25%
EPS 5Y2.72%
EPS Q2Q%-9.28%
EPS Next Y14.15%
EPS Next 2Y14.18%
EPS Next 3Y13.85%
EPS Next 5Y11.69%
Revenue 1Y (TTM)9.8%
Revenue growth 3Y11.64%
Revenue growth 5Y8.54%
Sales Q2Q%6.36%
Revenue Next Year7.47%
Revenue Next 2Y7.93%
Revenue Next 3Y8.08%
Revenue Next 5Y7.95%
EBIT growth 1Y6.44%
EBIT growth 3Y4.66%
EBIT growth 5Y5.57%
EBIT Next Year31.02%
EBIT Next 3Y17.05%
EBIT Next 5Y13.93%
FCF growth 1Y-52.56%
FCF growth 3Y-24.77%
FCF growth 5Y-17.33%
OCF growth 1Y-34.64%
OCF growth 3Y-19.49%
OCF growth 5Y-8.71%